| NO |
Title |
Date |
Submission Obligator |
| 10 |
Organization of Investor Relations Event |
2019/10/31 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Interim Report on Business Performance(Fair Disclosure) |
2019/10/28 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Organization of Investor Relations Event |
2019/09/03 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Organization of Investor Relations Event |
2019/08/26 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
Implementation and Operation of Compliance Program of the Fair Trade Commission |
2019/08/22 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
[Investment Caution]small number of branches being focused on |
2019/08/07 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Designation of overheated short-selling issues (applied by a restriction on short-selling) |
2019/08/05 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
Interim Report on Business Performance(Fair Disclosure) |
2019/07/30 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Organization of Investor Relations Event |
2019/06/05 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Organization of Investor Relations Event |
2019/05/14 |
HANALL BIOPHARMA CO.,LTD |